Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
about
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisAntibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisAntibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisDiagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' PerspectivesMycobacterium abscessus subsp abscessus lung disease: 'trouble ahead, trouble behind…'Current treatment of atypical mycobacteriosisClinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteriaTigecycline: a review of a new glycylcycline antibioticAntimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assayPharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy SubjectsNovel paradigms for drug discovery: computational multitarget screeningClinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infectionsConditional gene expression in Mycobacterium abscessus.Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains.Tigecycline: a novel broad-spectrum antimicrobial.High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections.Prosthetic joint infection caused by Mycobacterium alvei in an elderly patient.Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria.Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Tigecycline: a new glycylcycline for treatment of serious infections.The antimicrobial armamentarium: evaluating current and future treatment options.Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in JapanClinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases.Tigecycline for the treatment of infections due to resistant Gram-positive organisms.Role of mycobacterial efflux transporters in drug resistance: an unresolved question.Tigecycline: a novel glycylcycline antibiotic.Non-tuberculous mycobacterial infections.Mycobacterium abscessus: an emerging rapid-growing potential pathogen.Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom.Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseaseDaptomycin and tigecycline: a review of clinical efficacy in the antimicrobial era.Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts.Pharmacokinetic and pharmacodynamic evaluation of tigecycline.Mycobacterium abscessus: a new antibiotic nightmare.Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model.
P2860
Q24187458-DF9F942A-A44E-4B92-96B3-10C630736013Q24202353-3B406BB4-9289-4AFD-BA48-8AA4E283AF75Q24202502-50B28381-B19E-4605-8C9B-E23D02B7228BQ26749480-F030EEE4-0A44-4A0F-9D1D-2EFD6B7CEB7FQ26822822-5EA63FA5-86FC-493B-A5F2-5EFCB530D47BQ28265322-EF9E3DC7-0F67-47E5-8441-54FACB446DF7Q28278933-5A075D96-A2DA-4DB1-B318-850C411AA34BQ28278979-8C194830-F5A9-4504-8542-1134C64E6C37Q28538099-4E86A794-B7BF-4D35-84BC-8292A191DD97Q29398341-9A769BC7-9044-4486-BD51-73BA62272275Q30662767-810C42A2-7E18-42CE-8BE0-EF63F439A6A2Q33746042-4B06161F-D23E-44D2-93E9-8CF751972456Q34110899-EAE926B7-8745-4991-9516-F2DEA980B6F8Q34596782-80CB114E-FEBE-4A44-BACC-3684BD683DD5Q34630833-70DF0499-7FC6-4C07-B5C1-21DCD0DCBCB8Q35014132-8D8C843A-D26D-4018-BE7F-975F2044F2DCQ35127941-2C6EA56D-1785-4505-A5CC-30AF01BAF169Q35139867-F978B979-A5C1-4EFB-BD7E-EBD2E2061908Q35637071-886DCA57-2454-4191-9109-20DAB968620AQ35779935-45C2D8DE-3DCB-46FA-9A09-A466F17C4DC1Q35876393-2BC15CB1-FFFF-49BC-BE97-5BBD23CF0BEBQ36156072-27C81F04-FA2F-4D92-B841-AE1E4027F477Q36218312-6FB4C243-5673-4AA0-AD29-70DDA4E483A8Q36264494-2CCBD3ED-BED4-4447-8993-010908919FDFQ36299968-A6808ABE-147C-40D6-9EAB-893881AE9FE8Q36363027-903FF67D-361C-480F-AA3A-E68C4BA729B4Q36376443-D955BC49-E7CD-4606-8AEC-FC52B4B18308Q36378353-561B28E1-F6F6-4151-9AA3-8D56BB4A82B0Q36379330-29D32D5D-73A4-45F1-9854-A1BB37AA7327Q36482309-BA19B93A-76CB-4153-A9D5-4456908776D8Q36489352-02A2E8FF-CC9D-4576-8525-5C368F5D6FACQ36506301-EA90B802-1DF7-46FA-887C-1B3A0B41550EQ36875804-69F5206E-0E50-4374-8D5C-605BBBD83C5BQ36887811-C450E6EF-55E3-4837-B9F3-F27F7833AA08Q36967265-89D4A2FC-E0C5-425A-B800-4B8DFF42A504Q37144834-31066A4F-AA7A-47FB-9902-87D39240A194Q37803294-4E3988BA-F858-43CC-856D-A76EE97D1A8EQ37940546-92268561-697B-41A6-ACA4-49582575A7B2Q37980031-5FF3435C-629F-4671-9051-65910A97E5FEQ38441471-663EE792-16C4-4C8D-AE9C-E17BB3C4172D
P2860
Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Comparison of the in vitro act ...... f nontuberculous mycobacteria.
@en
Comparison of the in vitro act ...... f nontuberculous mycobacteria.
@nl
type
label
Comparison of the in vitro act ...... f nontuberculous mycobacteria.
@en
Comparison of the in vitro act ...... f nontuberculous mycobacteria.
@nl
prefLabel
Comparison of the in vitro act ...... f nontuberculous mycobacteria.
@en
Comparison of the in vitro act ...... f nontuberculous mycobacteria.
@nl
P2093
P2860
P1476
Comparison of the in vitro act ...... f nontuberculous mycobacteria.
@en
P2093
Barbara A Brown-Elliott
Christopher J Crist
Linda Mann
Rebecca W Wilson
Richard J Wallace
P2860
P304
P356
10.1128/AAC.46.10.3164-3167.2002
P407
P577
2002-10-01T00:00:00Z